Oxide terpenes as human skin penetration enhancers of haloperidol from ethanol and propylene glycol and their modes of action on stratum corneumVADDI, Haranath Kumar; HO, Paul Chi-Lui; CHAN, Yew Weng et al.Biological & pharmaceutical bulletin. 2003, Vol 26, Num 2, pp 220-228, issn 0918-6158, 9 p.Article

Alterations in NMDA receptor subunit levels in the brain regions of rats chronically administered typical or atypical antipsychotic drugsHANAOKA, Tadahito; TOYODA, Hirotaka; MIZUNO, Takafumi et al.Neurochemical research. 2003, Vol 28, Num 6, pp 919-924, issn 0364-3190, 6 p.Article

Effect of Rosiglitazone, a PPAR-γ Ligand on Haloperidol-Induced CatalepsyGUPTA, Gaurav; SINGH, Ramandeep; SHEBA RANI DAVID et al.CNS neuroscience & therapeutics (Print). 2013, Vol 19, Num 9, pp 724-725, issn 1755-5930, 2 p.Article

Anti-amnesic effect of dimemorfan in miceWANG, Hui-Hung; CHIEN, Jyh-Wei; CHOU, Yueh-Ching et al.British journal of pharmacology. 2003, Vol 138, Num 5, pp 941-949, issn 0007-1188, 9 p.Article

The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variationLINGJUN ZUO; XINGGUANG LUO; KRYSTAL, John H et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 6, pp 437-446, issn 1744-6872, 10 p.Article

Stability Studies of Clonazepam, Diazepam, Haloperidol, and Doxepin with Diverse Polarities in an Acidic EnvironmentMASLANKA, Anna; KRZEK, Jan; STOLARCZYK, Mariusz et al.Journal of AOAC International. 2011, Vol 94, Num 6, pp 1791-1799, issn 1060-3271, 9 p.Article

Despite irreversible binding, PET tracer [¹¹C]-SA5845 is suitable for imaging of drug competition at sigma receptors : The cases of ketamine and haloperidolKORTEKAAS, Rudie; MAGUIRE, R. Paul; VAN WAARDE, Aren et al.Neurochemistry international. 2008, Vol 53, Num 1-2, pp 45-50, issn 0197-0186, 6 p.Article

Interindividual variation of serum haloperidol concentrations in Japanese patients: clinical considerations on steady-state serum level-dose ratiosYUKAWA, E; ICHIMARU, R; MAKI, T et al.Journal of clinical pharmacy and therapeutics (Print). 2003, Vol 28, Num 2, pp 97-101, issn 0269-4727, 5 p.Article

The timing of haloperidol administration does not affect its prophylactic antiemetic efficacyYANG, Yao L; LAI, Hsien Y; WANG, Jhi J et al.Canadian journal of anaesthesia. 2008, Vol 55, Num 5, pp 270-275, issn 0832-610X, 6 p.Article

Delayed reactivation of haloperidol induced photosensitive dermatitis by methotrexateTHAMI, G. P; KAUR, S; KANWAR, A. J et al.Postgraduate medical journal. 2002, Vol 78, Num 916, pp 116-117, issn 0032-5473Article

Neuroleptic malignant syndrome : An atypical presentationNG, D.Current therapeutics. 1997, Vol 38, Num 11, pp 63-64, issn 0311-905XArticle

Optimal haloperidol dosage in first-episode psychosisZHANG-WONG, J; ZIPURSKY, R. B; BEISER, M et al.Canadian journal of psychiatry. 1999, Vol 44, Num 2, pp 164-167, issn 0706-7437Conference Paper

Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidolGIEGLING, Ina; DRAGO, Antonio; RUJESCU, Dan et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 4, pp 206-216, issn 1744-6872, 11 p.Article

La découverte de l'halopéridol = The discovery of haloperidolGRANGER, B.L' Encéphale (Paris). 1999, Vol 25, Num 1, pp 59-66, issn 0013-7006Conference Paper

Haloperidol plasma levels and dose optimizationCORYELL, W; MILLER, D. D; PERRY, P. J et al.The American journal of psychiatry. 1998, Vol 155, Num 1, pp 48-53, issn 0002-953XArticle

Effects of a quaternary pyridinium metabolite of haloperidol (HP⁺) on the viability and catecholamine levels of cultured PC12 cellsFANG, J; YU, P. H.Canadian journal of physiology and pharmacology. 1997, Vol 75, Num 8, pp 996-1000, issn 0008-4212Article

Haloperidol: towards further understanding of the structural contributions of its pharmacophoric elements at D2-like receptorsSIKAZWE, Donald M. N; SHOUMING LI; MARDENBOROUGH, Leroy et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 23, pp 5739-5742, issn 0960-894X, 4 p.Article

Metabolism of haloperidol and its tetrahydropyridine dehydration product HPTPUSUKI, E; VAN DER SCHYF, C. J; CASTAGNOLI, N. JR et al.Drug metabolism reviews (Softcover ed.). 1998, Vol 30, Num 4, pp 809-826, issn 0360-2532Article

BEYOND THE BASAL GANGLIA: cFOS EXPRESSION IN THE CEREBELLUM IN RESPONSE TO ACUTE AND CHRONIC DOPAMINERGIC ALTERATIONSHERRERA-MEZA, G; AGUIRRE-MANZO, L; CORIA-AVILA, G. A et al.Neuroscience. 2014, Vol 267, pp 219-231, issn 0306-4522, 13 p.Article

A SIMPLE METHOD FOR DETECTION OF FOOD FORAGING BEHAVIOR IN THE RAT: INVOLVEMENT OF NMDA AND DOPAMINE RECEPTORS IN THE BEHAVIORLI, F; CAO, W. Y; LI, M. B et al.Neuroscience. 2012, Vol 205, pp 73-80, issn 0306-4522, 8 p.Article

Haloperidol modulates noradrenergic responses to aversive stimulation depending on treatment durationAMATO, Davide; NATESAN, Sridhar; KAPUR, Shitij et al.Behavioural brain research. 2011, Vol 221, Num 1, pp 311-313, issn 0166-4328, 3 p.Article

Interaction of haloperidol plasma level and antipsychotic effect in early phases of acute psychosis treatmentGIEGLING, Ina; DRAGO, Antonio; SCHÄFER, Martin et al.Journal of psychiatric research. 2010, Vol 44, Num 8, pp 487-492, issn 0022-3956, 6 p.Article

HOMER SPLICE VARIANTS MODULATION WITHIN CORTICO-SUBCORTICAL REGIONS BY DOPAMINE D₂ ANTAGONISTS, A PARTIAL AGONIST, AND AN INDIRECT AGONIST : IMPLICATION FOR GLUTAMATERGIC POSTSYNAPTIC DENSITY IN ANTIPSYCHOTICS ACTIONTOMASETTI, C; DELL'AVERSANO, C; IASEVOLI, F et al.Neuroscience. 2007, Vol 150, Num 1, pp 128-142, issn 0306-4522, 15 p.Article

Iontophoretic transdermal delivery of haloperidolALVAREZ-FIGUEROA, M. J; ARAYA-SILVA, I; DIAZ-TOBAR, C et al.Pharmaceutical development and technology. 2006, Vol 11, Num 3, pp 371-375, issn 1083-7450, 5 p.Article

Effects of antipsychotic and antidepressant drugs on action monitoring in healthy volunteersDE BRUIJN, Ellen R. A; SABBE, Bernard G. C; HULSTIJN, Wouter et al.Brain research. 2006, Vol 1105, pp 122-129, issn 0006-8993, 8 p.Conference Paper